References
- Dubinsky RM, Kabbani H, El-Chami Z, et al. Practice parameter: treatment of postherpetic neuralgia: an evidence-based report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2004;63:959-65
- Stankus SJ, Dlugopolski M, Packer D. Management of herpes zoster (shingles) and postherpetic neuralgia. Am Fam Physician 2000;61:2437-2444, 2447-2448
- Kost RG, Straus SE. Postherpetic neuralgia—pathogenesis, treatment, and prevention. N Engl J Med 1996;335:32-42
- Dworkin RH, White R, O’Connor AB, et al. Health care expenditure burden of persisting herpes zoster pain. Pain Med 2008;9:348-353
- Red Book Drug Topics. Montvale, NJ: Thomson Healthcare, 2009
- Lidoderm (lidocaine patch 5%) label. Available at: http://www.accessdata.fda.gov/drugsatfda_docs/label/2006/020612s008lbl.pdf. Accessed November 30, 2009
- Neurontin (gabapentin) label. Available at: http://www.accessdata.fda.gov/drugsatfda_docs/label/2009/020235s041,020882s028,021129s027lbl.pdf. Accessed November 30, 2009
- Lyrica (pregabalin) label. Available at: http://www.accessdata.fda.gov/drugsatfda_docs/label/2009/021446s013s014lbl.pdf. Accesses November 30, 2009
- Liedgens H, Hertel N, Gabriel A, et al. Cost-effectiveness analysis of a lidocaine 5% medicated plaster compared with gabapentin and pregabalin for treating postherpetic neuralgia: a German perspective. Clin Drug Invest 2008;28:583-601
- Dakin H, Nuijten M, Liedgens H, et al. Cost-effectiveness of a lidocaine 5% medicated plaster relative to gabapentin for postherpetic neuralgia in the United Kingdom. Clin Ther 2007;29:1491-1507
- Holahan J, Miller DM, Rousseau D. Dual eligibles: Medicaid enrollment and spending for Medicare beneficiaries in 2005. Kaiser Commission on Medicaid and the Uninsured Issue Brief, February 2009
- Tyring S. Management of herpes zoster and postherpetic neuralgia. J Am Acad Dermatol 2007;57:s136-142
- Gnann JW, Whitley RJ. Clinical practice. Herpes zoster. N Engl J Med 2002;347:340-346
- Dworkin RH, White R, O’Connor AB, et al. Healthcare costs of acute and chronic pain associated with a diagnosis of herpes zoster. J Am Geriatr Soc 2007;55:1168-1175
- Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40:373-383
- Romano PS, Roos LL, Jollis J. Adapting a clinical comorbidity index for use with ICD-9-CM administrative data. J Clin Epidemiol 1993;46:1075-1079
- Oster G, Berger A, Dukes E, et al. Use of potentially inappropriate pain-related medications in older adults with painful neuropathic disorders. Am J Geriatr Pharmacother 2004;2:163-170
- Rosenbaum PR, Rubin DB. The central role of the propensity score in observational studies for causal effects. Biometrika 1983;70:41-55
- Rosenbaum PR. Optimal matching for observational studies. J Am Stat Assoc 1989;84:1024-1032
- Rosenbaum PR, Rubin DB. Constructing a control group using multivariate matched sampling methods that incorporate the propensity score. Am Stat 1985;39:33-38
- Rascati KL, Smith MJ, Neilands T. Dealing with skewed data: an example using asthma-related costs of Medicaid clients. Clin Ther 2001;23:481-498
- Efron B, Tibshirani RJ. An Introduction to the Bootstrap. New York: Chapman & Hall, 1993
- SAS Institute. Jackknife and Bootstrap Analyses. http://support.sas.com/kb/24/982.html
- Gauthier A, Breuer J, Carrington D, et al. Epidemiology and cost of herpes zoster and post-herpetic neuralgia in the United Kingdom. Epidemiol Infect 2009;137:38-47 Epub 2008 May 9
- Rothberg MB, Virapongse A, Smith KJ. Cost-effectiveness of a vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. Clin Infect Dis 2007;44:1280-1288
- Harpaz R, Ortega-Sanchez IR, Seward JF. Advisory Committee on Immunization Practices (ACIP) Centers for Disease Control and Prevention (CDC). Prevention of herpes zoster: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2008;57:1-30
- Johnson RW, Wasner G, Saddier P, et al. Herpes zoster and postherpetic neuralgia: optimizing management in the elderly patient. Drugs Aging 2008;25:991-1006. doi: 10.2165/0002512-200825120-00002
- Johnson RW. Herpes Zoster and postherpetic neuralgia: a review of the effects of vaccination. Aging Clin Exp Res 2009;21:236-243
- Hornberger J, Robertus K. Cost-effectiveness of a vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. Ann Intern Med 2006;145:317-325
- Dworkin RH, Malone DC, Panarites CJ, et al. Impact of postherpetic neuralgia and painful diabetic peripheral neuropathy on health care costs. J Pain 2010;11:360-368. Epub 2009 Oct 22